WELCOME TO CANCER CONNECTION, a monthly online publication featuring the latest news and information for faculty and staff at Ohio State’s Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). In addition, an Event Update appears online on or about the middle of each month. If you have a news item for the Feb. 15 edition of Event Update, call 293-6825 or send an email message to robert.hecker@osumc.edu by Friday, Feb. 10.
 


 

POSTER ABSTRACTS FOR ANNUAL SCIENTIFIC MEETING DUE FEB. 10 
Residents, postdoctoral fellows and graduate students who want to submit an abstract for review in the poster competition at the OSUCCC – James 14th annual Scientific Meeting must do so by Feb. 10 using the abstract form on the 2012 ASM website. Click here to review the abstract and poster guidelines. To submit an abstract, click here. Read more:

SUBMIT YOUR ARTWORK FOR THE 2012 ART OF CANCER RESEARCH COMPETITION
To further the bridge between art and science at the OSUCCC – James, we would like to encourage you to submit your “scientific art” to be displayed and reviewed during the 14th Annual Scientific Meeting. Prizes will be awarded to the top three entries: First Place Prize – $200 Barnes & Noble gift card; Second Place Prize – $100 Barnes & Noble gift card; and Third Place Prize – $50 Barnes & Noble gift card. Entries will only be accepted by email and must be submitted as jpg, tiff, eps, or pdf files. Entries should be sent by email to Tara Kuisick at Tara.Kuisick@osumc.edu by 5 p.m. Wednesday, Feb. 22.

CROCE HONORED – At a Jan. 24 reception held in honor of his recent election to the prestigious Institute of Medicine (IOM) of the National Academies, Carlo Croce, MD (second from right), director of Human Cancer Genetics at Ohio State, is congratulated by (from left) Charles J. Lockwood, MD, dean of Ohio State’s College of Medicine; Steven G. Gabbe, MD, CEO of Ohio State’s Medical Center; and Michael A. Caligiuri, MD, director of Ohio State’s Comprehensive Cancer Center and CEO of The James Cancer Hospital and Solove Research Institute. All four spoke at the reception. Election to the IOM, one of the highest honors in the field of health and medicine, recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. Croce, whose research and discoveries are respected around the world, chairs the Department of Molecular Virology, Immunology and Medical Genetics in the College of Medicine and is a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James. He also holds the John W. Wolfe Chair in Human Cancer Genetics.    
 
DATE & TIME ESSENTIAL FOR ALL INFORMED CONSENT FORMS
During December’s Joint Commission visit at The James, surveyors found that the time of signature was not being included every time an Informed Consent form was completed. Anyone signing an Informed Consent form MUST INCLUDE BOTH DATE AND TIME along with the signature to show exactly when something has occurred during the treatment of a patient. The Centers for Medicare and Medicaid Services requires this. Click here for a flier to print and post.

SEVEN REQUIREMENTS MUST BE COMPLETED IN POST-PROCEDURE NOTES
December’s Joint Commission visit at The James found that staff were not consistently listing all seven required elements for post-procedure progress notes in the electronic medical record (EMR).

The seven required elements are: name of physician; name of assistant(s); procedure performed; description of each procedure finding; estimated blood loss; specimens removed; and post-procedure diagnosis.
 
Be sure to list all seven in your post-procedure notes after all procedures or surgeries. In addition, please print, share and post this reference flier. A Post-Procedure Progress Notes template is being created in IHIS. More information will be shared once the template is live.




 

REGISTER NOW FOR 2012 ASH REVIEW TAKING PLACE ON FEB. 24
Primary care physicians, hematology and oncology specialists, researchers in hematology, nurses and other healthcare professionals are encouraged to register for Ohio State’s 2012 American Society of Hematology (ASH) Review, which will unfold from 7:30 a.m.-3 p.m. on Friday, Feb. 24, in Room 115 of the Biomedical Research Tower. To register, visit cancer.osu.edu/go/ASHReview. Read more:

2012 PELOTONIA FELLOWSHIP SYMPOSIUM REGISTRATION IS OPEN
The cancer research of several 2010-11 undergrads, graduate students and postdoctoral fellows whose work is supported by funds raised through Pelotonia will be featured at the 2012 Pelotonia Fellowship Symposium from 8:30 a.m.-4:30 p.m. on Wednesday, May 30, in Room 115 of Ohio State’s Biomedical Research Tower, 460 W. 12th Avenue. To register, please visit go.osu.edu/2012FellowshipSymposium. Read more:

ABSTRACT SUBMISSIONS DUE FEB. 17 FOR ANNUAL TRAINEE RESEARCH DAY
Graduate students whose advisers are faculty in Ohio State’s College of Medicine, MD-PhD students, medical students, postdoctoral trainees, clinical residents or fellows, and undergrads enrolled in College of Medicine training programs are invited to submit abstracts for the 11th annual OSUMC Trainee Research Day to be held April 18-19 in the Biomedical Research Tower. Read more:

TRANSLATIONAL RESEARCH CONSORTIUM ANNUAL MEETING IS FEB. 22-24
“Cancer Vaccine and Immune Regulation” will be the theme for the 15th annual meeting of the Translational Research Cancer Centers Consortium (TRCCC) Feb. 22-24 at Seven Springs Mountain Resort in Pennsylvania. Three scientists from the OSUCCC – James, which is a member of the eight-institution consortium, will present during the meeting. Read more:

INDIVIDUALIZED RESEARCHMATCH TRAINING AVAILABLE
Scientists who are experienced with ResearchMatch or who are thinking about using it for recruitment purposes now have several opportunities for online training. Click here for a list of training classes and for more information.

RENOWNED SPEAKERS, POSTER SESSION TO HIGHLIGHT WOUND CONFERENCE
Experts from Ohio State and around the world will address the latest research-based clinical advances in wound care at the fifth annual Translational to Clinical (T2C) Wound Care Conference on Regenerative Medicine on March 23-24 at the Ohio Union. Read more:

COLLEGE OF DENTISTRY RESEARCH DAY WILL BE FEB. 29
Ohio State’s College of Dentistry will showcase research conducted by dental and dental hygiene students, graduate students, postdoctoral fellows and residents at the College’s 28th annual Research Day from 8:30 a.m.-1:30 p.m. on Wednesday, Feb. 29, at the Ohio Union (3rd Floor), 1739 N. High St. Distinguished Lecturer Jill Helms, DDS, PhD, a professor in the Department of Surgery, Division of Plastic and Reconstructive Surgery, at the Stanford University School of Medicine, will present “Regenerative Dental Medicine: Stem Cell Biology and Its Impact on Dentistry” at 9 a.m. Breakfast and lunch will be provided.

APPLICATIONS SOUGHT FOR OSU HHMI ‘MED INTO GRAD SCHOLARS PROGRAM’
The Ohio State University Howard Hughes Medical Institute (HHMI) “Med Into Grad Scholars Program” prepares predoctoral students to conduct research at the interface of basic biomedical science and clinical medicine. Program graduates are expected to expedite the clinical application of discoveries in biomedical science to improve human health and create future research partnerships with physicians. The program is accepting applications from precandidacy Ohio State graduate students until Feb. 24. Students interested in additional information or in applying to the program should contact Kathy Froilan at kathy.froilan@osumc.edu or visit http://medicine.osu.edu/go/hhmi.

NATIONWIDE CHILDREN'S RESEARCH INSTITUTE HOSTS HEM-ONC SPEAKER SERIES
The Research Institute at Nationwide Children's Hospital hosts a twice-monthly speaker series in which local hematology/oncology fellows, principal investigators, postdocs and graduate students report on advances in their pediatric cancer research. The sessions are held on the second and fourth Tuesdays of each month at the hospital, 700 Children’s Drive, Columbus, from 8:30-9:30 a.m. in Research Building II, Room WA1525. Each session is designed for a 35-45 minute talk followed by a question-and-answer session. A light refreshment is offered. Registration is not required, and everyone is welcome. 

EDUCATIONAL EVENTS WILL AID OSU RESEARCH COMMUNITY
Ohio State’s Office of Research and Administrative Research Council are planning educational events throughout February to assist the University’s research community. Registration is required at http://go.osu.edu/ORtraining. Here’s a list:

• Office of Research, “NCURA TV- International Collaborations: Negotiations and Compliance,” 11 a.m.-2 p.m., Wednesday, Feb. 8, 1960 Kenny Road, Room 113. This session will help researchers understand processes and policies that support international collaboration and the impact of critical compliance responsibilities, including providing essential export control and related information.
• Administrative Research Council, “ARC Meeting,” 9:30-11 a.m., Tuesday, Feb. 21, Physics Research Building, Room 1080. This meeting will include discussions on: building programs of funded research in health and wellness; research in view; updates on semester conversion and salary caps; and other research administration topics.
• Administrative Research Council, “ARC Discussions – Access the Power of the PI Portal,” noon-1 p.m., Thursday, Feb. 23, Physical Activities & Educational Services Building, Room A110. Researchers will learn how to use e-Activity data and find a potential collaborator to target funding agencies.
• Office of Research, “Cost Sharing on Sponsored Programs,” 10 a.m.-noon, Thursday, Feb. 23, Physics Research Building, Room 1080. This interactive presentation will include an overview of cost sharing, clarification of roles and responsibilities, and how to record cost sharing on sponsored programs.
• Office of Research, “Grant Writing: An Introduction,” 1:30-3:30 p.m., Wednesday, Feb. 29, Physics Research Building, Room 1080. This workshop will address similarities and differences between the funding process from federal/ state agencies and private foundations, in addition to talks about best practices for seeking funding.

‘TOOLS OF THE TRADE’ WORKSHOP SET FOR MARCH 6
Investigators from all disciplines across campus are invited to attend a free “Tools of the Trade” workshop sponsored by Ohio State’s Center for Clinical and Translational Science (CCTS) from 8 a.m.-4 p.m. on March 6 in the Ohio Union Cartoon Room. Designed for all levels of investigators but especially for those who are early in their careers, the workshop will cover writing manuscripts, grant writing, Responsible Conduct of Research, REDCap and basic statistics. Lunch will be provided. Registration is required at http://tinyurl.com/7f5xncq. You may also visit the CCTS website at www.ccts.osu.edu for more information. Questions? Contact Stephanie Vecchiarelli at ccts-education@osumc.edu.

All meetings will be from noon-1 p.m. in 518 James unless otherwise noted. Lunch is provided beginning at 11:45 a.m. RSVP to Nancy Jones at 293-3688 or nancy.jones@osumc.edu.

Special Seminar
Feb. 6 – Ao-Lin Allen Hsu, PhD, University of Michigan, 2:30 p.m. in Room 105 of the Biomedical Research Tower, “The Genetic and Pharmacological Factors That Influence Rate of Aging and Longevity in C. elegans”

Viral Oncology
Feb. 27 – Frederic Bushman, PhD, University of Pennsylvania, "Dynamics of the Human Microbiome"
 
Molecular Biology and Cancer Genetics
March 7 – Wei Hsu, PhD, University of Rochester, noon-1 p.m. in Room 155 of the Biomedical Research Tower, "A Wnt-Wnt Situation in Development and Cancer"

The 2011-12 Grand Rounds lecture series sponsored by the OSUCCC – James continues with presentations beginning at 8 a.m. in 518 James on Feb. 3, 17 and 24. Continental breakfast is available starting at 7:45 a.m. A one-page printable schedule of upcoming Grand Rounds presentations is available here.

The next three Grand Rounds speakers and their topics will be:

Feb. 3 – Denis Guttridge, PhD, associate professor in the Department of Molecular Virology, Immunology and Medical Genetics at Ohio State, and a member of the Molecular Biology and Cancer Genetics Program at the OSUCCC – James, "Insights Into the Mechanisms of Muscle Wasting in Cancer"

Feb. 17 – Timothy Ley, MD, Washington University in St. Louis, “The AML Genome”

Feb. 24 – Melissa Bondy, PhD, Baylor University College of Medicine, “Molecular and Genetic Epidemiology of Glioma” 

Biosketches of these speakers are available here.

ANTISENSE MIGHT MAKE SENSE FOR TREATING LIVER CANCER
A study by scientists at the OSUCCC – James and the Mayo Clinic shows it is possible to target and block a particular microRNA that is important in liver cancer, a finding that might offer a new therapy for this malignancy. The animal study focused on microRNA-221 (miR-221), a molecule that is consistently present at abnormally high levels in liver cancer. Read more:

STUDY REVEALS MECHANISM OF LUNG CANCER DRUG RESISTANCE
Research published in the journal Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs. The study, led by investigators at the OSUCCC – James, shows that overexpression of two genes, called MET and EGFR, causes the deregulation of six microRNAs, and that this deregulation leads to gefitinib resistance. Read more:

ORAL HPV INFECTION THREE TIMES MORE COMMON IN MEN THAN WOMEN
New research shows that men are three times more likely to have an oral human papilloma virus (HPV) infection than women. The findings help explain why HPV-related oral cancers are three times more common in men than women. Maura Gillison, MD, PhD, a medical oncologist and head and neck cancer specialist at the OSUCCC – James, led the study, which was published online Jan. 26 by the Journal of the American Medical Association to coincide with Gillison’s presentation of the findings at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix, Ariz. Read more:

PREEMINENT PEDIATRIC CANCER SPECIALIST JOINS NATIONWIDE CHILDREN’S HOSPITAL
Oncologist and cancer researcher Timothy P. Cripe, MD, PhD, has been appointed chief of the Division of Hematology/Oncology and Bone Marrow Transplantation at Nationwide Children’s Hospital.  He also is on the faculty at Ohio State’s College of Medicine and is a member of the Viral Oncology Program at the OSUCCC – James. Read more:

NEW CCTS WEBSITE COMING SOON
Ohio State’s Center for Clinical and Translational Science (CCTS) will soon launch a new version of its website with an improved look and feel, intuitive navigation and streamlined content. Read more:




Medical scientists at the OSUCCC – James frequently publish articles in prestigious scientific journals. Articles that have appeared in journals with an impact factor (IF) of 7.0 or above are listed each month in Cancer Connection. Articles that are still in press are not listed. Names shown in bold are members of the OSUCCC; a “+”signifies a former or retired OSUCCC member.

Ni Y, He X, Chen J, Moline J, Mester J, Orloff MS, Ringel MD, Eng C. Germline SDHx variants modify breast and thyroid cancer risks in Cowden and Cowden-like syndrome via FAD/NAD-dependent destabilization of p53. Human Molecular Genetics 2012;21(2):300-310.  IF: 8.058

Kim KB, Sosman JA, Fruehauf JP, Linette GP, Markovic SN, McDermott DF, Weber JS, Nguyen H, Cheverton P, Chen D, Peterson AC, Carson III WE, O'Day SJ. BEAM: A randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma. Journal of Clinical Oncology 2012;30(1):34-41.  IF: 18.97

Chakroborty D, Sarkar C, Yu H, Wang J, Liu Z, Dasgupta PS, Basu S. Dopamine stabilizes tumor blood vessels by upregulating angiopoietin expression in pericytes and Kruppel-like factor-2 expression in endothelial cells. Proceedings of the National Academy of Sciences of the USA  2011;108(51):20730-20735.  IF: 9.771

Gogna R, Madan E, Kuppusamy P, Pati U. Reactive oxygen species-mediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells. Antioxidants & Redox Signaling 2012;16(5):400-412.  IF: 8.209

NEW ‘QUIET PROTOCOL’ IMPLEMENTED
In an effort to make patient stays more restful so as to improve outcomes and raise patient-satisfaction scores, Ohio State’s Medical Center has implemented a new Quiet Protocol on patient units effective Wednesday, Feb. 1. Learn more about the Quiet Protocol.

NURSING RESEARCH DAY POSTER ABSTRACTS DUE FEB. 3
Nurses wishing to submit a poster abstract for the third annual James/OSU Health System Nursing Research Day must do so by Friday, Feb. 3. Guidelines and a submission form are available on the Nursing Research Day 2012 site. If you submit a poster, you are required to attend the event. This year’s event, titled “Nurturing Excellence Through Nursing Research,” is set for Tuesday, March 27, from 7:30 a.m.-4:15 p.m. in the Biomedical Research Tower, Room 115. Those who attend can explore opportunities to engage in the nursing research process. Registration is available via NetLearning.

CLIMBING CANCER CONQUEROR TO SHARE HIS STORY FEB. 9
Nurses throughout Ohio State’s Medical Center are invited to hear Sean Swarner – a two-time cancer survivor, mountain climber, speaker and author – share his story of healing, hope and triumph from 10-10:50 a.m. on Thursday, Feb. 9, in James 518. Swarner will be visiting patients at The James before delivering his motivational lecture to nurses that morning.

At age 13, he was diagnosed with stage IV Hodgkin disease. Doctors gave him just three months to live, but with treatment he kept improving until at age 15 he was in remission. When he was 16, doctors discovered a tumor (Askin sarcoma) in his chest wall and gave him only two weeks to live. Some 15 years later, with only partial use of his lungs, Swarner climbed Mt. Everest and later wrote a book titled Keep Climbing: How I Beat Cancer and Reached the Top of the World. He now shares his inspirational story with patients and professionals in hospitals worldwide.

Nurses interested in attending his lecture or getting more information should RSVP by Feb. 7 to Katie Jones at katie.jones@osumc.edu. Light refreshments will be provided. Click here for a flier to print and post.





COLORECTAL CANCER COVERED AT UPCOMING CONFERENCE
Cancer survivors, family members, friends and health professionals can learn what every patient should know about colorectal cancer diagnosis and treatment at a free Colorectal Conference from 9 a.m.-1 p.m. on Saturday, March 10, at Ohio State’s Eye and Ear Institute, 915 Olentangy River Road. Tanios Bekaii-Saab, MD, medical director of the Gastrointestinal Oncology Program at the OSUCCC – James, and other members of Ohio State’s gastrointestinal team will talk about advances in colorectal cancer treatment, symptom management, clinical trials, and screening and prevention. Breakfast and lunch will be provided. This conference is presented in collaboration with the Columbus Chapter of the Oncology Nursing Society. Registration is required by calling 293-6428 or visiting cancer.osu.edu/go/support. 

‘EVENING WITH AN AUTHOR’ SLATED FOR FEB. 2
Author and cancer survivor Brian Kraft will share from his book, The Year My Dad Went Bald, at an Evening With an Author presentation hosted by JamesCare for Life from 6-8 p.m. on Thursday, Feb. 2, at the Stefanie Spielman Comprehensive Breast Center, 1145 Olentangy River Road. The book is written from the perspective of the author’s 9-year-old son. A panel discussion will follow, and time will be allotted for questions. To register, call 293-6428 or visit cancer.osu.edu/go/support.
 
‘CANCER TRANSITIONS’ SERIES DESIGNED FOR POST-TREATMENT PATIENTS
Post-treatment patients and their caregivers can benefit from a six-week series called “Cancer Transitions: Moving Beyond Treatment” to be held on Mondays from Feb. 6 through March 12 from 6:30-8 p.m. at the Stefanie Spielman Comprehensive Breast Center, 1145 Olentangy River Road. The series will feature nutrition, exercise, stress management and tools for follow-up care. Class size is limited, so register early at 293-6428 or cancer.osu.edu/go/support.  

JAMESCARE FOR LIFE CLASSES LISTED
As part of its supportive cancer care program offerings, JamesCare for Life will present several classes or workshops for adult cancer survivors in the weeks ahead. All are free, but registration is required at cancer.osu.edu/go/support or by calling 293-6428. Click here for a list of classes.





USAC FOCUS GROUPS SEEK STAFF FEEDBACK, INPUT
The University Staff Advisory Committee (USAC) will hold a series of seven focus groups from mid-February to early March to gather feedback from staff about their satisfaction as Ohio State employees. Participants will be randomly chosen and contacted via email to participate. The USAC strongly encourages those who are invited to register for a focus group and attend. For additional information, contact USAC Chair Heather Link.

SERVICE BOARD ACCEPTING GRANT APPLICATIONS FOR JULY 2012-13
The Medical Center Service Board is accepting grant applications for July 2012-June 2013 projects. Through its annual grant process, the Service Board funds projects that enhance the patient and family experience. The grants cannot fund pharmaceuticals or diagnostic/treatment/medical equipment. Typically, funded grants range from $25 to $10,000. Any Medical Center department may apply. Download the grant guidelines and application form. The application can be completed electronically but must be printed for signatures and submission. All required supporting documents must be attached. The deadline to submit applications is March 1 by 5 p.m. Contact Donna Thimdit in Volunteer Services at 293-8653 with questions. 

ID PROCESSING & SECURITY OFFICE WILL MOVE FEB. 17
On Feb. 17, ID Processing, along with the administrative offices within the Department of Security, will move to the 5th Floor of Cramblett Medical Clinic until July. ID Processing will be in Room 5013. This temporary move will accommodate construction of a concourse that will connect the new James Cancer Hospital and Solove Research Institute and Critical Care Tower to Rhodes Hall. ID Processing will maintain normal hours of operation at its interim location. The Control Center for Security will remain at its current site on the first floor of Rhodes Hall.

APPLY BY FEB. 20 TO PARTICIPATE IN COLLEGE OF MEDICINE ART SHOW
The Medicine and the Arts Board of Ohio State’s College of Medicine invites students, faculty and staff to submit original works to the College’s Art Show to be held March 6-8. The show will open with a reception at 4 p.m. on March 6 in the Meiling Hall lobby, where the works will be displayed. Read more:

BLOOD DRIVE FEB. 3 IN ROSS HEART HOSPITAL
Eligible faculty and staff are encouraged to give blood at the next Medical Center Blood Drive, which will be held from 11 a.m.-5 p.m. on Friday, Feb. 3, in the Richard M. Ross Heart Hospital lobby. To schedule an appointment, visit redcrossblood.org (sponsor code: buckeyes) or call 1-800-RED CROSS. You can enter to win free groceries from Kroger for a year and receive a Tim Horton’s donut coupon. If you last donated on or before Dec. 9, you may be eligible to donate.

NATIONAL WEAR RED DAY IS THIS FRIDAY, FEB. 3
Friday is National Wear Red Day so wear scarlet in support of heart disease prevention!

NOMINATE A CO-WORKER FOR BRAVO VALUES IN ACTION AWARD
Do you know a colleague who consistently demonstrates the Medical Center’s values? Nominations for the Values in Action Awards are being accepted until Feb. 9 for Quarter 3, FY 12. A nomination form is available on OneSource. You may return completed nominations to the Faculty and Staff Recognition Office in 155 Doan Hall, email them to BRAVO@osumc.edu or fax them to 293-9182. In addition, Values in Action Team nominations recognize Medical Center teams for working together in different situations. Nominations for the team award are accepted throughout the year. View a list of previous Values in Action recipients and read how these individuals portray and live the Medical Center’s Values.

DISTINGUISHED STAFF AWARD NOMINATIONS SOUGHT
Ohio State’s Office of Human Resources is accepting nominations for the Distinguished Staff Award. These awards will honor 12 staff members for outstanding leadership and accomplishments in service to the University. Nominations are due by 5 p.m. Feb. 13. An interactive form and more information are available here. Call 292-4341 with questions.

DIVERSITY ENHANCEMENT AWARD NOMINATIONS DEADLINE EXTENDED
The Senate Diversity Committee, in partnership with Ohio State’s Office of Human Resources, is still accepting nominations for the 2012 Distinguished Diversity Enhancement Award. This annual awards program will recognize up to five units or individuals who have demonstrated a significant commitment to enhancing diversity at Ohio State. Nominations are due by 5 p.m. Friday, Feb. 3. An interactive form and more information are available here. Call 292-4341 to learn more.

PELOTONIA ’12 REGISTRATION NOW OPEN
Registration is open for Pelotonia ’12, the annual grassroots bicycle tour that raises money for research at the OSUCCC – James. Visit teambuckeye.osu.edu to register for this year’s event, which is scheduled for Aug. 10-12 on assorted routes between Columbus and Kenyon, Ohio. Team Buckeye is the official superpeloton of The Ohio State University and includes faculty, staff, students, alumni, friends and family of the Buckeye Nation. Questions? Contact Karl Koon at karl.koon@osumc.edu.


NEXT PELOTONIA FELLOWSHIP APPLICATIONS DUE MARCH 1
The Pelotonia Fellowship Program is accepting applications for undergraduate, graduate, medical student and postdoctoral fellowships to be awarded to students in any field of study who want to pursue a cancer-related project with a faculty mentor at the OSUCCC – James.  

“We encourage all students who would like to do cancer research to apply for a fellowship,” says Jeff Mason, director of the Pelotonia Fellowship Program. “To date, 116 fellowships have been awarded to students in many fields of study, including arts and sciences, business, engineering, humanities, medicine and pharmacy. This year we expect to award another 49 fellowships.”

Applications are due March 1. For more information, including eligibility guidelines and an application, visit http://cancer.osu.edu/go/pelotoniafellowship or send an e-mail to Jeffrey.Mason@osumc.edu.

SILENT AUCTION WILL SUPPORT PELOTONIA
The Team Buckeye Student Riders will host a Silent Auction from 6-9 p.m. on Wednesday, Feb. 8, at Woody’s Tavern in the Ohio Union to help their peloton raise money for Pelotonia ‘12. Everyone is invited to stop by and support this event, where you can name your price on such items as Kaplan test kits, Target gift cards, President E. Gordon Gee’s bow tie, a Camelot Cellars wine experience and a 2012 Fuji road bike. All proceeds will benefit cancer research at the OSUCCC – James.





STEP & STRIDE FASHION & FITNESS WALK SET FOR FEB. 19
Register now to participate in the third annual Step & Stride Fashion & Fitness Walk (5K). Join 10TV's Karina Nova for a walk through The Mall at Tuttle Crossing on Sunday, Feb. 19, at 10:30 a.m. Proceeds will benefit the Hereditary Colon Cancer Fund at the OSUCCC – James. Participants will receive an event T-shirt and a goodie bag filled with coupons, samples and deals at the mall. The registration fee is $25 for adults and $5 for children 18 and under. To register, visit www.stepandstride.com

U.S. Sen. Sherrod Brown (at lectern) addresses the national drug shortage crisis
at a Jan. 19 roundtable discussion hosted by the OSUCCC – James. At left are
breast cancer patient Sharon Brown and Michael Grever, MD, chair of Internal
Medicine at Ohio State and co-leader of the Experimental Therapeutics Program
at the OSUCCC – James.

LEGISLATIVE SOLUTIONS SOUGHT FOR NATIONAL DRUG SHORTAGE
U.S. Sen. Sherrod Brown will work with the OSUCCC – James to explore legislative action to address a drug-shortage crisis affecting hospitals and patient care across the nation. Read more:





VOLUNTEER OFFICE TO MOVE LATER THIS MONTH
The James Volunteer Office will move to the fifth floor of Doan Hall in mid- to late-February to enhance the patient/family experience and accommodate the new James Cancer Hospital and Solove Research Institute and Medical Center Expansion. Read more:

PATIENT/FAMILY ADVISORY COUNCIL TO MEET FEB. 16
The James Patient/Family Advisory Council will hold its next bi-monthly meeting from noon-2:30 p.m. on Thursday, Feb. 16, in James 518A. The council comprises 20 patients/family members who serve as a link between James staff/administration and patients by providing feedback on hospital policies and practices that shape patient care.

“As advocates for the needs of patients and families, the Advisory Council promotes better understanding and communication between healthcare providers and those they serve,” says Sharon Cross, LISW, patient/family experience adviser and program manager. Staff interested in learning more or in presenting to the Council should contact Cross at sharon.cross@osumc.edu.

A. Douglas Kinghorn, PhD, DSc, the Jack L. Beal Professor and Chair in Natural Products Chemistry and Pharmacognosy at Ohio State’s College of Pharmacy, recently received an Honorary Doctor of Science degree from the University of Bradford (Bradford, West Yorkshire, United Kingdom). A 1969 graduate of Bradford in Pharmacy, and a current member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, Kinghorn received his honorary doctorate in recognition of his considerable contribution to the field of pharmacognosy through the isolation, characterization and biological evaluation of natural (plant-derived) compounds. Kinghorn is principal investigator of a collaborative multidisciplinary program project titled “Discovery of Anticancer Agents of Diverse Natural Origin” that is funded by the National Cancer Institute. The primary objective is to discover natural product anticancer agents from tropical plants, aquatic cyanobacteria and filamentous fungi. Kinghorn earned his PhD in 1975 and his DSc in 1990, both from the University of London. He has authored or co-authored some 470 research articles, book chapters and reviews, and he received the 2010 Norman R. Farnsworth Research Achievement Award of the American Society of Pharmacognosy. He has served as editor-in-chief of the Journal of Natural Products since 1994.

David Schuller, MD, vice president for medical center expansion and outreach, is one of five individuals who will be inducted into the Rutgers Hall of Distinguished Alumni on May 5. Schuller, a graduate of the Rutgers University Class of 1966, is an internationally renowned physician clinical scientist known for his lifesaving developments in treating cancers of the head and neck. He is a former director and deputy director of Ohio State’s Comprehensive Cancer Center (OSUCCC), and he directed The James from 1988 – two years before it officially opened – until 2008. He is now director emeritus of the OSUCCC and CEO emeritus of The James. He also holds the John W. Wolfe Chair in Cancer Research. A biosketch on the Rutgers website credits Schuller for 30 years of research focusing on novel therapeutic strategies for the treatment of head and neck malignancies. In the 1990s he chaired a research leadership team in a national study that changed the standard of care for patients with advanced nasopharyngeal cancers. After graduating from Rutgers, Schuller completed a surgical internship at University Hospitals of Case Western Reserve University and a residency in otolaryngology/head and neck surgery at Ohio State, where he joined the faculty in 1976. He later chaired the Department of Otolaryngology – Head and Neck Surgery for 21 years, leading it to national stature. 2012 marks the 25th anniversary of the Rutgers Hall of Distinguished Alumni. Slightly more than 200 Rutgers graduates have been inducted.